Star Health and Allied Insurance Company Limited — Investor Meet, 31-01-2025: Analysts/Institutional Investor Meet/Con. Call Updates

1. **Financial Performance:** Star Health's gross written premium (GWP) increased by 16% for the nine months of FY '25, with fresh GWP growing by 27%. Retail health GWP saw a 14% rise, maintaining a market share of 32.2%. However, the combined ratio rose to 101.8% from 98.3% YoY, driven by an increased claims ratio of 70.7%. Investment income grew to ₹996 Crore, with a 15% increase in investment assets, now at ₹16,666 Crore. Profit Before Tax (PBT) stood at ₹862 Crore, while Profit After Tax (PAT) was ₹645 Crore, with a return on equity (ROE) of 9.7%.

2. **Future Outlook and Growth Drivers:** Management expressed optimism about retail market expansion, new product launches, and their ongoing "risk first, growth later" strategy. Focus remains on maintaining solid underwriting standards while leveraging increased agency strength, which accounted for 80% of overall business.

3. **Order Book and Operational Updates:** The digital segment performed well, contributing 8% to GWP with a 58% increase in fresh business. Agency recruitment grew, adding 19,000 agents in the December quarter. Fresh business growth for retail health reached 22%, emphasizing continuing efforts on both value and volume sides.

4. **Analyst Q&A Insights (Detailed):**

- **Revenue and Profitability:** Management clarified that GWP growth was slightly inflated by accounting changes. Analysts noted risks of elevated expense ratios and prospects for weaker PAT in Q4 due to reserve additions.

- **Market Position and Competitive Landscape:** Competitive pressures are evident, with pricing strategies needing sensitivity to avoid market share loss. Despite challenges, the incremental improvements in claims management were noted.

- **Operational Challenges or Risks:** Management acknowledged industry-wide claims ratio challenges and outlined steps to improve performance, including product repricing and strategic underwriting adjustments.

- **Capex and Capital Allocation:** Management remains committed to investing in marketing and agent recruitment while adapting to regulatory changes affecting commission structures.

- **Strategic Priorities and Long-Term Vision:** There is a clear focus on innovation and expansion within the retail space, striving for sustained growth while addressing claims and adherence to regulatory compliance.

5. **Market or Regulatory Updates:** The shift to the "1/N" accounting framework affects GWP reporting but aligns with broader industry practices aiming at increased transparency and performance accuracy.

6. **Strategic Focus Areas:** Key themes include improving customer service through enhanced claims management and digital platforms, strategies to manage costs effectively, and ongoing price adjustments to combat medical inflation.

7. **Investor Insight:** Given the strong market position, significant growth in retail segments, and proactive management responses to operational challenges, the outlook suggests a favorable trajectory that aligns with a ‘buy’ position, acknowledging potential short-term volatility as the company adapts to regulatory frameworks and adjusts pricing strategies.